{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:35:58Z","timestamp":1773876958773,"version":"3.50.1"},"reference-count":49,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"},{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"},{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["Division of Preclinical Innovation"],"award-info":[{"award-number":["Division of Preclinical Innovation"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15POST24870001"],"award-info":[{"award-number":["15POST24870001"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F32HL131288"],"award-info":[{"award-number":["F32HL131288"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16POST27760002"],"award-info":[{"award-number":["16POST27760002"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL071818"],"award-info":[{"award-number":["HL071818"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL122416"],"award-info":[{"award-number":["HL122416"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["13SDG17230049"],"award-info":[{"award-number":["13SDG17230049"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Lecithin:cholesterol acyltransferase (LCAT) and LCAT-activating compounds are being investigated as treatments for coronary heart disease (CHD) and familial LCAT deficiency (FLD). Herein we report the crystal structure of human LCAT in complex with a potent piperidinylpyrazolopyridine activator and an acyl intermediate-like inhibitor, revealing LCAT in an active conformation. Unlike other LCAT activators, the piperidinylpyrazolopyridine activator binds exclusively to the membrane-binding domain (MBD). Functional studies indicate that the compound does not modulate the affinity of LCAT for HDL, but instead stabilizes residues in the MBD and facilitates channeling of substrates into the active site. By demonstrating that these activators increase the activity of an FLD variant, we show that compounds targeting the MBD have therapeutic potential. Our data better define the substrate binding site of LCAT and pave the way for rational design of LCAT agonists and improved biotherapeutics for augmenting or restoring reverse cholesterol transport in CHD and FLD patients.<\/jats:p>","DOI":"10.7554\/elife.41604","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T19:00:12Z","timestamp":1543258812000},"source":"Crossref","is-referenced-by-count":42,"title":["Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol"],"prefix":"10.7554","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-8228","authenticated-orcid":true,"given":"Kelly A","family":"Manthei","sequence":"first","affiliation":[{"name":"Life Sciences Institute, University of Michigan, Ann Arbor, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1928-136X","authenticated-orcid":true,"given":"Shyh-Ming","family":"Yang","sequence":"additional","affiliation":[{"name":"National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolormaa","family":"Baljinnyam","sequence":"additional","affiliation":[{"name":"National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Chang","sequence":"additional","affiliation":[{"name":"Life Sciences Institute, University of Michigan, Ann Arbor, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa","family":"Glukhova","sequence":"additional","affiliation":[{"name":"Life Sciences Institute, University of Michigan, Ann Arbor, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and Biointerfaces Institute, University of Michigan, Ann Arbor, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lita A","family":"Freeman","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Cardiovascular-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Maloney","sequence":"additional","affiliation":[{"name":"National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Schwendeman","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and Biointerfaces Institute, University of Michigan, Ann Arbor, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan T","family":"Remaley","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Cardiovascular-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-1451","authenticated-orcid":true,"given":"Ajit","family":"Jadhav","sequence":"additional","affiliation":[{"name":"National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-3727","authenticated-orcid":true,"given":"John JG","family":"Tesmer","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Purdue University, Indiana, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4374","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallographica Section D Biological Crystallography"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/B978-0-12-407867-3.00007-X","volume-title":"The HDL Handbook: Biological Functions and Clinical Implications","author":"Ahsan","year":"2014"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2011.11.034","article-title":"Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease","volume":"222","author":"Calabresi","year":"2012","journal-title":"Atherosclerosis"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1194\/jlr.M082685","article-title":"Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides","volume":"59","author":"Casteleijn","year":"2018","journal-title":"Journal of Lipid Research"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/8904_2017_57","article-title":"Novel missense lcat gene mutation associated with an atypical phenotype of familial lcat deficiency in two portuguese brothers","volume":"40","author":"Castro-Ferreira","year":"2018","journal-title":"JIMD Reports"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/ndt\/gfm311","article-title":"Molecular characterization of two patients with severe LCAT deficiency","volume":"22","author":"Charlton-Menys","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallographica Section D Biological Crystallography"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.metabol.2011.08.006","article-title":"Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters","volume":"61","author":"Chen","year":"2012","journal-title":"Metabolism"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1194\/jlr.M085332","article-title":"A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL","volume":"59","author":"Cooke","year":"2018","journal-title":"Journal of Lipid Research"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1074\/jbc.271.4.2023","article-title":"Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange","volume":"271","author":"Czarnecka","year":"1996","journal-title":"Journal of Biological Chemistry"},{"key":"bib11","article-title":"Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders","volume-title":"United States Patent","year":"1999","unstructured":"Dassuex J-L, Sekul R, Buttner K, Cornut I, Metz G, Dufourcq J. 1999. Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders. United States Patent. 6004925. https:\/\/patents.google.com\/patent\/US6004925."},{"key":"bib12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallographica Section D Biological Crystallography"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/0006-291X(72)90776-0","article-title":"A protein cofactor of lecithin:cholesterol acyltransferase","volume":"46","author":"Fielding","year":"1972","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1124\/jpet.117.240457","article-title":"Lecithin:Cholesterol acyltransferase activation by sulfhydryl-reactive small molecules: role of cysteine-31","volume":"362","author":"Freeman","year":"2017","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithins:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"Journal of Lipid Research"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1038\/ncomms7250","article-title":"Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase","volume":"6","author":"Glukhova","year":"2015","journal-title":"Nature Communications"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1074\/jbc.M115.672790","article-title":"Agonistic human antibodies binding to lecithin-cholesterol acyltransferase modulate high density lipoprotein metabolism","volume":"291","author":"Gunawardane","year":"2016","journal-title":"Journal of Biological Chemistry"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N","article-title":"Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme","volume":"30","author":"Hayward","year":"1998","journal-title":"Proteins: Structure, Function, and Genetics"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1472-6807-8-49","article-title":"HOLLOW: generating accurate representations of channel and interior surfaces in molecular structures","volume":"8","author":"Ho","year":"2008","journal-title":"BMC Structural Biology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2005.08.038","article-title":"Compound heterozygosity (G71R\/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease","volume":"187","author":"H\u00f6rl","year":"2006","journal-title":"Atherosclerosis"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1388-1981(00)00153-0","article-title":"Lecithin cholesterol acyltransferase","volume":"1529","author":"Jonas","year":"2000","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"bib22","article-title":"Methods for treating atherosclerosis","volume-title":"United States Patent","year":"2013","unstructured":"Kayser F, Labelle M, Shan B, Zhang J, Zhou M. 2013. Methods for treating atherosclerosis. United States Patent. 8426358. https:\/\/patents.google.com\/patent\/US8426358."},{"key":"bib23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrd4279","article-title":"HDL-targeted therapies: progress, failures and future","volume":"13","author":"Kingwell","year":"2014","journal-title":"Nature Reviews Drug Discovery"},{"key":"bib24","article-title":"Piperidinylpyrazolopyridine derivative","volume-title":"United States Patent","year":"2015","unstructured":"Kobayashi H, Ohkawa N, Takano M, Kubota H, Onoda T, Kaneko T, Arai M, Terasaka N. 2015a. Piperidinylpyrazolopyridine derivative. United States Patent. 9150575. https:\/\/patents.google.com\/patent\/US9150575."},{"key":"bib25","article-title":"Condensed Pyrazole Derivative","volume-title":"World Intellectual Property Organization","year":"2015","unstructured":"Kobayashi H, Onoda T, Kaneko T, Ishibashi K. 2015b. Condensed Pyrazole Derivative. World Intellectual Property Organization. 2015111545. https:\/\/patents.google.com\/patent\/WO2015111545A1\/en."},{"key":"bib26","article-title":"5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative","volume-title":"United States Patent","year":"2016","unstructured":"Kobayashi H, Arai M, Kaneko T, Terasaka N. 2016. 5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative. United States Patent. 9796709. https:\/\/patents.google.com\/patent\/US9796709."},{"key":"bib27","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1107\/S0907444904026460","article-title":"Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions","volume":"60","author":"Krissinel","year":"2004","journal-title":"Acta Crystallographica Section D Biological Crystallography"},{"key":"bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","article-title":"The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes","volume":"38","author":"Kuivenhoven","year":"1997","journal-title":"Journal of Lipid Research"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"Journal of Chemical Information and Modeling"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-17350-4_3","volume-title":"Apolipoprotein Mimetics in the Management of Human Disease","author":"Li","year":"2015"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"20313","DOI":"10.1074\/jbc.M117.802736","article-title":"A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I","volume":"292","author":"Manthei","year":"2017","journal-title":"Journal of Biological Chemistry"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1107\/S0907444906045975","article-title":"Solving structures of protein complexes by molecular replacement with Phaser","volume":"63","author":"McCoy","year":"2007","journal-title":"Acta Crystallographica Section D Biological Crystallography"},{"key":"bib33","first-page":"59","volume-title":"Molecular Defects in the Lecithin:Cholesterol Acyltransferase Gene","author":"McLean","year":"1992"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1358\/dot.2013.49.4.1940984","article-title":"Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis","volume":"49","author":"McPhail","year":"2013","journal-title":"Drugs of Today"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallographica Section D Biological Crystallography"},{"key":"bib36","article-title":"Imidazopyridine Derivative","volume-title":"World Intellectual Property Organization","year":"2015","unstructured":"Onoda T, Kaneko T, Arai M, Kobayashi H, Terasaka N. 2015. Imidazopyridine Derivative. World Intellectual Property Organization. 2015087996. https:\/\/patents.google.com\/patent\/WO2015087996A1\/en."},{"key":"bib37","doi-asserted-by":"publisher","first-page":"e0150083","DOI":"10.1371\/journal.pone.0150083","article-title":"Lipoprotein X Causes Renal Disease in LCAT Deficiency","volume":"11","author":"Ossoli","year":"2016","journal-title":"PLOS ONE"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods in Enzymology"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"Journal of Computational Chemistry"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1194\/jlr.M059873","article-title":"The high-resolution crystal structure of human LCAT","volume":"56","author":"Piper","year":"2015","journal-title":"Journal of Lipid Research"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2005.01.048","article-title":"Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes","volume":"182","author":"Pisciotta","year":"2005","journal-title":"Atherosclerosis"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cmet.2016.01.005","article-title":"New therapeutic approaches to the treatment of dyslipidemia","volume":"23","author":"Rader","year":"2016","journal-title":"Cell Metabolism"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MED.0b013e328329233b","article-title":"Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease","volume":"16","author":"Rousset","year":"2009","journal-title":"Current Opinion in Endocrinology, Diabetes and Obesity"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11883-011-0171-6","article-title":"Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?","volume":"13","author":"Rousset","year":"2011","journal-title":"Current Atherosclerosis Reports"},{"key":"bib45","volume-title":"Comprehensive Analysis of the Renal and Systemic Phenotypes Associated with Familial Deficiency of Lecithin-Cholesterol Acyltransferase: A Case Series","author":"Sampaio","year":"2017"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jacl.2015.12.007","article-title":"Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement","volume":"10","author":"Shamburek","year":"2016","journal-title":"Journal of Clinical Lipidology"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/CIRCRESAHA.115.306223","article-title":"Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study","volume":"118","author":"Shamburek","year":"2016","journal-title":"Circulation Research"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/01913123.2010.551578","article-title":"Lecithin: Cholesterol Acyltransferase (LCAT) Deficiency: renal lesions with early graft recurrence","volume":"35","author":"Str\u00f8m","year":"2011","journal-title":"Ultrastructural Pathology"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archopht.1988.01060130235035","article-title":"Ophthalmic observations in lecithin cholesterol acyltransferase deficiency","volume":"106","author":"Vrabec","year":"1988","journal-title":"Archives of Ophthalmology"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/41604\/elife-41604-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/41604\/elife-41604-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/41604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:02:23Z","timestamp":1697058143000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/41604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":49,"alternative-id":["10.7554\/eLife.41604"],"URL":"https:\/\/doi.org\/10.7554\/elife.41604","archive":["CLOCKSS"],"relation":{"is-supplemented-by":[{"id-type":"uri","id":"http:\/\/www.rcsb.org\/structure\/6MVD","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/422725","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.41604.031","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.41604.032","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"article-number":"e41604"}}